7-Fluoro-6-nitro-4-hydroxyquinazoline: A Key Intermediate for Advanced Cancer Therapies
Discover the critical role of 7-Fluoro-6-nitro-4-hydroxyquinazoline (CAS 162012-69-3) in the synthesis of life-saving kinase inhibitors and its impact on targeted cancer treatments.
Get a Quote & SampleProduct Core Value
7-Fluoro-6-nitro-4-hydroxyquinazoline
As a dedicated supplier in China, we provide high-quality 7-Fluoro-6-nitro-4-hydroxyquinazoline, a pivotal pharmaceutical intermediate essential for the development of advanced kinase inhibitors. Its unique chemical structure serves as a critical building block in the synthesis of potent oncology drugs, contributing significantly to the advancement of targeted cancer therapies.
- Leverage our expertise as a trusted manufacturer in China to secure high-purity pharmaceutical intermediates like 7-Fluoro-6-nitro-4-hydroxyquinazoline for your R&D needs.
- Explore the crucial role of kinase inhibitor intermediates in developing targeted cancer therapies, ensuring greater efficacy and reduced side effects.
- Utilize 7-Fluoro-6-nitro-4-hydroxyquinazoline as a key intermediate in the preparation of EGFR inhibitors, advancing the fight against various cancers.
- Benefit from our commitment to quality and consistency, ensuring reliable raw materials for complex pharmaceutical synthesis processes.
Advantages Provided by the Product
Precision in Kinase Inhibition
The compound's specific chemical architecture makes it an ideal precursor for molecules designed to precisely inhibit target kinases, a cornerstone of modern oncology drug discovery.
Enabling Targeted Cancer Therapies
By serving as a crucial intermediate, it directly supports the creation of targeted cancer therapies, offering a more effective and often less toxic approach than traditional chemotherapy.
Accelerating Drug Development
Access to high-quality 7-Fluoro-6-nitro-4-hydroxyquinazoline from reliable suppliers accelerates the drug discovery pipeline, bringing innovative treatments to patients faster.
Key Applications
Oncology Drug Synthesis
As a vital component in the preparation of kinase inhibitors, this intermediate is fundamental for synthesizing novel anticancer drugs.
EGFR Inhibitor Development
Its quinazoline scaffold is key for creating drugs targeting the epidermal growth factor receptor, crucial for treating certain types of cancer.
Pharmaceutical Research
Enables researchers to explore new molecular entities and optimize existing drug candidates in the field of medicinal chemistry.
Chemical Synthesis Building Blocks
Provides essential functional groups and a core structure for complex organic synthesis and the creation of specialized APIs.